Bouldoukian Kevork MD is categorized under Internal Medicine Practitioners in Bakersfield, CA and active since 2006.
Bouldoukian Kevork MD was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Kevork Bouldoukian at the company’s single location by writing to 2128 Truxtun Avenue, Bakersfield, California CA 93301 or by phoning (661) 633-9080. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bouldoukian Kevork MD |
| Contact Person: | Kevork Bouldoukian |
| Address: | 2128 Truxtun Avenue, Bakersfield, California 93301 |
| Phone Number: | (661) 633-9080 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Bouldoukian Kevork MD was started in 2006 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Kevork Bouldoukian for inquiries that concern Bouldoukian Kevork MD by calling the company number (661) 633-9080, as your correspondence is most welcome. Additionally, the physical location of the single location of Bouldoukian Kevork MD can be found at the coordinates 35.37348,-119.02673 as well as the street address 2128 Truxtun Avenue in Bakersfield, California 93301.
For its online presence, you may visit Bouldoukian Kevork MD’s website at and engage with its social media outlets through on Twitter and on Facebook.